BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 28813639)

  • 1. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
    Kamel HFM; Al-Amodi HSAB
    Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New directions in biomarker research, drug development and personalized medicine].
    Németh G; Jelinek I
    Magy Onkol; 2013 Mar; 57(1):5-10. PubMed ID: 23573515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive biomarkers: tools in personalized oncology.
    Nalejska E; Mączyńska E; Lewandowska MA
    Mol Diagn Ther; 2014 Jun; 18(3):273-84. PubMed ID: 24385403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical development of biomarkers for personalized medicine].
    Saito M; Yoshino T
    Nihon Rinsho; 2010 Jun; 68(6):1111-6. PubMed ID: 20535964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.
    Supplitt S; Karpinski P; Sasiadek M; Laczmanska I
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards defining biomarkers indicating resistances to targeted therapies.
    Stehle F; Schulz K; Seliger B
    Biochim Biophys Acta; 2014 May; 1844(5):909-16. PubMed ID: 24269379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine.
    Aftimos PG; Barthelemy P; Awada A
    Discov Med; 2014 Feb; 17(92):81-91. PubMed ID: 24534471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive genomic biomarkers.
    Kumar R; Amado RG
    Curr Top Microbiol Immunol; 2012; 355():173-88. PubMed ID: 21877260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
    Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
    BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in targeted therapy and biomarker research in thyroid cancer.
    Guo M; Sun Y; Wei Y; Xu J; Zhang C
    Front Endocrinol (Lausanne); 2024; 15():1372553. PubMed ID: 38501105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
    Bertotti A; Migliardi G; Galimi F; Sassi F; Torti D; Isella C; Corà D; Di Nicolantonio F; Buscarino M; Petti C; Ribero D; Russolillo N; Muratore A; Massucco P; Pisacane A; Molinaro L; Valtorta E; Sartore-Bianchi A; Risio M; Capussotti L; Gambacorta M; Siena S; Medico E; Sapino A; Marsoni S; Comoglio PM; Bardelli A; Trusolino L
    Cancer Discov; 2011 Nov; 1(6):508-23. PubMed ID: 22586653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future of personalized medicine in oncology: a systems biology approach.
    Gonzalez-Angulo AM; Hennessy BT; Mills GB
    J Clin Oncol; 2010 Jun; 28(16):2777-83. PubMed ID: 20406928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.
    Kelleher MT; Fruhwirth G; Patel G; Ofo E; Festy F; Barber PR; Ameer-Beg SM; Vojnovic B; Gillett C; Coolen A; Kéri G; Ellis PA; Ng T
    Target Oncol; 2009 Sep; 4(3):235-52. PubMed ID: 19756916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualized precision medicine].
    Wullich B; Taubert H; Goebell PJ; Kuwert T; Beck M; Schott C; Baur AS; Eckstein M; Wach S
    Urologie; 2023 Sep; 62(9):879-888. PubMed ID: 37526710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy.
    Nowsheen S; Whitley AC; Yang ES
    Curr Mol Med; 2012 Jul; 12(6):788-803. PubMed ID: 22292444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor biomarkers for diagnosis, prognosis and targeted therapy.
    Zhou Y; Tao L; Qiu J; Xu J; Yang X; Zhang Y; Tian X; Guan X; Cen X; Zhao Y
    Signal Transduct Target Ther; 2024 May; 9(1):132. PubMed ID: 38763973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.
    Normanno N; Rachiglio AM; Roma C; Fenizia F; Esposito C; Pasquale R; La Porta ML; Iannaccone A; Micheli F; Santangelo M; Bergantino F; Costantini S; De Luca A
    J Cell Biochem; 2013 Mar; 114(3):514-24. PubMed ID: 22991232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive biomarkers for tumor-relevant signaling pathways in molecular pathology].
    Bonzheim I; Fend F
    Pathologe; 2014 Feb; 35(1):93-105. PubMed ID: 24496994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review.
    Bibault JE; Fumagalli I; Ferté C; Chargari C; Soria JC; Deutsch E
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):479-92. PubMed ID: 23595306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.